A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results